BNET Industries

Antex Biologics Inc.

is in the Pharma Industry

Last Fiscal Year Sales:$17.5M
  • Private
  • US
Dow Jones Description

Emergent BioSolutions is a biologics company focused on the research, development and manufacture of novel vaccines and related products for prophylactic and therapeutic use against common diseases and biological weapons of mass destruction. Its subsidiaries are BioPort Corporation, the primary manufacturing operation, headquartered in Lansing, Michigan, and research-focused Emergent, located in Gaithersburg, Maryland. A leading presence in the biodefense industry with a strong financial position, exciting developmental pipeline and experienced management team, Emergent BioSolutions is very well placed to become the leading supplier of biodefense vaccines in the world. Emergent BioSolutions was formed in March 2004. It is the parent company of BioPort and Emergent, and will be the vehicle for other acquisitions in the future.

President and Chief Executive Officer, Emergent Biodefense Operations Lansing Inc.
Robert G Kramer
Number of Employees 34
Contact Information

300 Professional Dr

Gaithersburg, Maryland 20879-3419

www.antexbiolog...

1 301 590 0129

NAICS Code Biological Product (except Diagnostic) Manufacturing: 325414

News & Analysis

antex biologics inc. - All News and Analysis

  • Antex Biologics Awarded NIAID Grant to Continue Development of Helicobacter pylori Vaccine

    - 2004-07-09

    LANSING, Mich. -- Antex Biologics, a wholly-owned subsidiary of Emergent BioSolutions and sister company to BioPort Corporation, has received a $2 million grant from the National Institute of Allergy and Infectious Disease a division of the National Institutes of Health in connection with its Helicobacter pylori (H. pylori) vaccine candidate....

    Tags: Antex Biologics Inc.

  • BioPort Corp. completes acquisition of Antex Biologics

    - 2003-06-05

    BioPort Corp., of Lansing, Mich., completed its acquisition of the assets of bankrupt Antex Biologics Inc., of Gaithersburg, for $3.4 million, following approval by the bankruptcy court. Antex develops and markets products to prevent and treat chronic bacterial infections and related diseases. BioPort manufactures the world's only FDA-licensed vaccine to...

    Tags: Antex Biologics Inc.

  • BioPort buys Antex Biologics. (News in Brief).(Brief Article)

    - 2003-03-24

    BioPort Corp., which makes an anthrax vaccine BioThrax, has agreed to acquire Antex Biologics. Inc., a company developing vaccines and antibiotics, for $3 million. Antex has strategic alliances with GlaxoSmithKline PLC, Aventis and the Department of Defense.

    Tags: Antex Biologics Inc.

  • Gaithersburg-based Antex Biologics to be acquired by Michigan's

    - 2003-03-19

    BioPort Corp., of Lansing, Mich., which makes anthrax vaccine, announced its intention to acquire Antex Biologics Inc., a Gaithersburg-based company that develops and markets products to prevent and treat chronic bacterial infections and related diseases, for either $3 million in cash or a combination of cash and stock valued at...

    Tags: Antex Biologics Inc.

  • BioPort Corporation to Purchase the Assets of Antex Biologics

    - 2003-03-17

    Business Editors/Health/Medical Writers BIOWIRE2K LANSING, Mich.--BUSINESS WIRE--March 17, 2003 BioPort Corporation today announced that it has executed a discretionary loan agreement and a non-binding letter of intent with Antex Biologics, Inc. (AMEX:ANX), with the intention of acquiring substantially all of the assets of the Maryland-based company. ...

    Tags: Antex Biologics Inc.

  • Antex Biologics.

    - 2003-01-22

    M2 PRESSWIRE-22 January 2003-Research and Markets: Antex BiologicsC1994-2003 M2 COMMUNICATIONS LTD RDATE:01212003 This company profile for Antex Biologics is taken directly from the BiotechWatch database. The BiotechWatch database is a continuously updated interactive database that follows such parameters...

    Tags: Antex Biologics Inc.

  • ANTEX GETS FIVE NEW INTERNATIONAL PATENTS.

    - 2003-01-01

    Antex Biologics Inc. (Amex: ANX), Gaithersburg, Md., has been issued five new patents, increasing the company's total patent portfolio to 116 issued patents. The company also has over 300 pending patent applications. Antex's worldwide patent portfolio includes claims for composition of matter, methods...

    Tags: Antex Biologics Inc.

  • Antex Biologics reports net loss of $2.4M

    - 2002-08-06

    Antex Biologics Inc., of Gaithersburg, which develops and markets products to prevent and treat chronic bacterial infections and related diseases, reported a second-quarter net loss of $2.4 million, or 22 cents per diluted share, on revenue of $85,000, versus a net loss of $1.7 million, or 14 cents per diluted...

    Tags: Antex Biologics Inc.

  • Antex Biologics Inc. of Gaithersburg completes clinical trial of

    - 2002-06-05

    Antex Biologics Inc., Gaithersburg, completed the subject dosing segment of a Phase II human clinical trial for a component of its ACTIVAX combination vaccine to prevent Travelers' Diseases. The trial is being conducted at the Walter Reed Army Institute for Medical Research in Forest Glen.

    Tags: Antex Biologics Inc.

  • Dept. of Defense requests white paper from Antex Biologics about its

    - 2002-05-29

    The Department of Defense requested Gaithersburg-based Antex Biologics Inc. to submit a white paper describing the qualities of its antibiotic compound, AP 158, as both a therapeutic drug for skin and soft tissue infections, and as a decontaminating agent in combating bioterrorism.

    Tags: Antex Biologics Inc.

Decision Makers

Name (plus bio) Position
Robert G Kramer President and Chief Executive Officer, Emergent Biodefense Operations Lansing Inc.
Daniel Abdun-Nabi President, Coo & Secretary
Michael J Langford President, Emergent Product Development Gaithersburg Inc.
Steven Chatfield President, Epd Uk, Cso
Edward J. Arcuri COO and Executive Vice President and Chief Operating Officer
Jonathan Pockson CFO and Senior Vice President and Chief Financial Officer
R Don Elsey Senior Vice President Finance and Administration, Chief Financial Officer
Thomas K. Zink Senior Vice President Medical Affairs and Chief Medical Officer
Denise Esposito Senior Vice President Legal Affairs and General Counsel
Kyle Keese Senior Vice President Manufacturing Operations
Mauro Gibellini Senior Vice President Corporate Development
Daniel Abdun
Fuad El
Jay Coupe
Jerome M. Hauer Director
Louis W. Sullivan Director
Zsolt P Harsanyi Director

Board of Directors

Name (plus bio) Position
Fuad El-Hibri Chairman of the Board of Directors
Ronald Richard Chair
Dr Shahzad Malik Board of Directors
Joe M. Allbaugh Board of Directors
Robert Myers Board of Directors

Organization Position Status
Antex Biologics, Inc. President and Chief Executive Officer, Emergent Biodefense Operations Lansing Inc. Current
Bioport President Former
Bioport Chief Operating Officer Former
Antex Biologics, Inc. Executive Vice President, Maufacturing Operations Former
Clemson University B.S. In Industrial Management Former
Western Kentucky University M.B.A. Former
Clemson University B.S. In Industrial Management Former

Organization Position Status
Antex Biologics, Inc. President, Coo & Secretary Current
Antex Biologics, Inc. Senior Vice President Former
BioVeris Corporation General Counsel Former
University of San Diego School of Law J.D. Former
Georgetown University Law Center Master of Laws, Taxation Former
University of Massachusetts Amherst B.A. In Political Science Former

Organization Position Status
Antex Biologics, Inc. President, Emergent Product Development Gaithersburg Inc. Current
Iowa State University Dvm Former
University of Hawaii Ph.D. Former

Organization Position Status
Antex Biologics, Inc. President, Epd Uk, Cso Current
University of Birmingham Ph.D. Former

Organization Position Status
Antex Biologics, Inc. COO and Executive Vice President and Chief Operating Officer Current
MedImmune, Inc. Senior Vice President, Manufacturing Operations Current
Rensselaer Polytechnic Institute Ph.D. Former

Organization Position Status
Antex Biologics, Inc. CFO and Senior Vice President and Chief Financial Officer Current
University of Lancaster MSc in Law Former

Organization Position Status
Antex Biologics, Inc. Senior Vice President Finance and Administration, Chief Financial Officer Current
Upmc-Cbn.Org Senior Vice President Finance & Administration and Chief Financial Officer Current
Applera Corporation Director of Finance Former
BioVeris Corporation Director of Finance and Administration Former
Michigan State University M.B.A. In Finance Former
Michigan State University B.A. In Economics Former

Organization Position Status
Antex Biologics, Inc. Senior Vice President Medical Affairs and Chief Medical Officer Current
GlaxoSmithKline Plc Director of Immunization Practices and Scientific Affairs Former
Prudential Insurance Company of America Medical Director Former
University of Missouri-Kansas City Physician Former
University of Missouri-Kansas City B.A., M.D. Former

Organization Position Status
Antex Biologics, Inc. Senior Vice President Legal Affairs and General Counsel Current
Upmc-Cbn.Org Senior Vice President Legal Affairs, General Counsel and Secretary Current
Emergent BioSolutions Inc. General Counsel & Senior Vice President, Legal Affairs Former
The University of Michigan Law School J.D. Former
Rutgers University B.A. In Economics Former

Organization Position Status
Upmc-Cbn.Org Senior Vice President Manufacturing Operations Current
Antex Biologics, Inc. Senior Vice President Manufacturing Operations Current
Emergent BioSolutions Inc. Vice President of Sales and Marketing Former
Antex Biologics, Inc. Vice President, Business Development Former
Antex Biologics, Inc. Sales Executive Former
Abbott Laboratories Former
National University M.B.A. Former
Tulane University B.A. In Mathematics Former

Organization Position Status
Antex Biologics, Inc. Senior Vice President Corporate Development Current
Upmc-Cbn.Org Senior Vice President Corporate Affairs Current
Goldman, Sachs & Co. Former
Bioport Former
Marymount University B.A. In Business Administration Former

Organization Position Status
Antex Biologics, Inc. Current
U.S. Securities and Exchange Commission Former
University of San Diego School of Law J.D. Former

Organization Position Status
Antex Biologics, Inc. Current
Booz Allen Hamilton, Inc. Resident Project Manager Former
Citigroup Inc. manager Former
Yale University Masters Degree in Public and Private Management Former
Stanford University Bachelors Degree with Honors in Economics Former

Organization Position Status
Antex Biologics, Inc. Current
Boston University Master's Degree in International Communications Former
Princeton University B.A. in English Former

Organization Position Status
Antex Biologics, Inc. Chairman of the Board of Directors Current
East West Resources Chairman Current
Antex Biologics, Inc. Chief Executive Officer Former
Digicel, Inc. President Former
East West Resources President Former
Yale University Master's Degree In Public and Private Management Former
Stanford University B.A. In Economics Former

Organization Position Status
The Cleveland Foundation President Current
University of Oxford Officer Current
Cambridge University Officer Current
Nonprofitpanel.Org Current
Antex Biologics, Inc. Chair Current
Emergent BioSolutions Inc. Board of Directors Current
Antex Biologics, Inc. Director Current
Community Partnership Board of Directors Current
Ohio Grantmakers Forum Board of Directors Current
The Cleveland Foundation Chief Executive Officer Current
Central Intelligence Agency Chief Operating Officer Former
In-Q-Tel, Inc. Managing Partner Former
Bennett College Professor Former
Spelman College Former
Matsushita Electric Industrial Co., Ltd Former
Notre Dame College Doctorate In Humane Letters Former
The Johns Hopkins University Master's Degree In International Relations Former
Johns Hopkins University School of Advanced International Studies M.A. In International Relations Former
Washington University Bachelor's Degree In History Former

Organization Position Status
Advent Venture Partners Llp. General Partner Current
Advent Inc. Current
Antex Biologics, Inc. Board of Directors Current
Cardiokine, Inc Board of Directors Current
Respivert Ltd. Board of Directors Current
McKinsey & Company, Inc. Physician Former
Cambridge University M.D. Former
University of Oxford M.A. In Physiological Sciences Former

Jerome M. Hauer Chief Executive Officer, The Hauer Group Mr. Hauer, age 55, has served as a member of our board of directors since June 2004. Mr. Hauer is recognized as one of the nation’s leading experts on bioterrorism and emergency preparedness, with over 20 years of experience in emergency management. Mr. Hauer currently serves as Chief Executive Officer of The Hauer Group LLC, a consulting firm. Previously, Mr. Hauer served as Senior Vice President, Fleishman-Hillard Government Relations from January 2005 to March 2006. He previously served as Executive Director of the Response to Emergencies and Disasters Institute (READI) and Associate Professor, School of Public Health at The George Washington University from November 2003 to October 2004. During the events of September 11, 2001 and the nation’s anthrax crisis that followed, Mr. Hauer served as Senior Advisor to the Secretary of Health and Human Services (HHS) for National Security and Emergency Management from June 2001 to November 2003. In June 2002, HHS Secretary Tommy G. Thompson named Mr. Hauer as Acting Assistant Secretary for the Office of Public Health Emergency Preparedness. In this role, Mr. Hauer was responsible for coordinating the country’s medical and public health preparedness and response to emergencies, including acts of biological, chemical and nuclear terrorism. Prior to serving at HHS, Mr. Hauer worked with Mayor Rudolph W. Giuliani as the first Director of the Mayor’s Office of Emergency Management for New York City, charged with coordinating the city’s emergency response plans from February 1996 to March 2000. Mr. Hauer is a member of the Johns Hopkins School of Public Health’s Health Advisory Board and has served on the National Academy of Sciences Institute of Medicine’s Committee to Evaluate R&D Needs for Improved Civilian Medical Response to Chemical or Biological Terrorism Incidents. Mr. Hauer is the recipient of numerous honors, including the Outstanding Alumni of the Year from the Johns Hopkins School of Public Health, the Indiana Commendation Medal for Exceptional Meritorious Service, the Legion of Hoosier Heroes Award and the Distinguished Alumni Award from NYU. He also is a member of the New York City Police Department’s Honor Legion, and is an honorary Assistant Chief in the New York City Fire Department. Mr. Hauer graduated from New York University with a B.A. degree in psychology and history and from the Johns Hopkins School of Public Health with a Master’s degree.

Organization Position Status
Hollis-Eden Pharmaceuticals, Inc. Board of Directors Current
The Hauer Group, Inc. Chief Executive Officer Former
Antex Biologics, Inc. Director Current
Hollis-Eden Pharmaceuticals, Inc. Chief Executive Officer, the Hauer Group Former
Fleishman-Hillard Government Relations Senior Vice President and Co-Chair Former
Kroll Associates Managing Director of the Crisis and Consequence Management Group Former
Fleishman-Hillard Inc. Former
Fleishman-Hillard Government Relations Co-Chair Former
Emergency Medical Services Corporation Director Former
Response, Inc. Director Former
New York University Master Former
New York University B.A. Former

Organization Position Status
The Allbaugh Company, LLC Chief Executive Officer Current
The Allbaugh Company, LLC President Current
Ecosphere Technologies Inc President of Ecosphere Systems and Director Current
Ftl Solar, LLC Board of Directors Current
Emergent BioSolutions Inc. Board of Directors Current
Citadel Security Software Inc. Board of Directors Current
Ecosphere Technologies Inc Director Current
Compressus, Inc. Board of Directors Current
The National Rifle Association Board of Directors Current
Antex Biologics, Inc. Board of Directors Current
American Revolution Former
Federal Emergency Management Agency Director Former
Oklahoma State University Bachelor of Arts In Political Science Former

Louis Sullivan served as U.S. Secretary of Health and Human Services from 1989 to 1993. Prior to and following his service as HHS Secretary, he was President of Morehouse School of Medicine, which he now serves as President Emeritus. He is co-chair of The Presidential Advisory Council on HIV/AIDS. A graduate of Morehouse College, he earned his medical degree from Boston University, and is certified in internal medicine and hematology. The recipient of 45 honorary degrees, he served on the faculties of the medical schools at Harvard, Seton Hall, and Boston universities before arriving at Morehouse in 1975. He was also the founding president of the Association of Minority Health Professions Schools.

Organization Position Status
The National Health Museum, Inc U.S. Secretary of Health and Human Services Current
Caligor, Inc. Secretary Current
Biosante Pharmaceuticals, Inc. Board of Directors Current
McDonald's Corporation Current
Go Active Current
Protect The Truth Current
National Families In Action Current
Biosante Pharmaceuticals, Inc. Chair of Board Current
United Therapeutics Corporation Board of Directors Current
Jonas Center for Nursing Excellence Board of Directors Current
Consumer Health Services, Inc. Board of Directors Current
Emergent BioSolutions Inc. Director Current
The National Health Museum, Inc Board of Directors Current
Minority Health Board of Directors Current
Phi Beta Kappa Board of Directors Current
Henry Schein, Inc. Board of Directors Current
Inhibitex, Inc. Board of Directors Current
Antex Biologics, Inc. Director Current
Bristol-Myers Squibb Company Board of Directors Current
Georgia-Pacific Corporation Board of Directors Current
Boyscouts.Com Board of Directors Current
Inhibitex, Inc. Member Current
3M Company President Former
More House President Former
Boston City Hospital Founder Former
Medical Education Founder Former
Morehouse College Director of The Medical Education Program Former
Morehouse College Dean Former
Harvard Medical School Instructor Former
Morehouse School of Medicine Trustee Former
Morehouse School of Medicine President Former
Harvard Corporation Former
Equifax Inc. Board of Directors Former
3M Company Board of Directors Former
CIGNA Corporation Board of Directors Former
Human Services Inc Secretary Former
Health-Corp Secretary Former
Care and Company Board of Directors Former
Caligor, Inc. Secretary Former
Ethics Resource Center Board of Directors Former
Boston University M.D. Former
Morehouse College B.S. Former
Boston University Medical Degree Former
Boston University School of Medicine Degree Former

Organization Position Status
Antex Biologics, Inc. Board of Directors Current

Organization Position Status
Exponential Biotherapies, Inc. Chairman of the Board of Directors & CEO Current
N-Gene Research Laboratories, Inc. President of Porton International and Dynaport Current
Antex Biologics, Inc. Director Current
N-Gene Research Laboratories, Inc. Board of Directors Current
Emergent BioSolutions Inc. Board of Directors Current
E.F. Hutton Vice President of Corporate Finance Former
Albert Einstein College of Medicine Ph.D. Former
Albert Einstein College Ph.D. Degree Former
Amherst College B.A. Degree Former

Executive News

  • BioSante Pharmaceuticals and Cell Genesys Sign Definitive Merger Agreement

    NewsBlaze - 8/29/09 - View Story

  • Emergent BioSolutions Expands Manufacturing and Development Infrastructure Through a Series of...

    Forbes.com - 8/06/09 - View Story

  • Emergent BioSolutions Expands Manufacturing and Development Infrastructure Through a Series of Real Estate Transactions

    Business Wire - 8/06/09 - View Story